Showing results (131-140 of 497) with videos related to
Sort By:
Pageof 50
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 25, 2013
Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosisMichele Boldrini, Francesco Salinaro, Roberta Mussinelli, et al.Blood|July 20, 2016
Treatment recommendations from the Eighth International Workshop on Waldenström's MacroglobulinemiaVéronique Leblond, Efstathios Kastritis, Ranjana Advani, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 13, 2009
Optimal sensorimotor control in eye movement sequencesJérôme Munuera, Pierre Morel, Jean-René Duhamel, et al.Clinical Nuclear Medicine|March 6, 2015
Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathySimone Longhi, Rachele Bonfiglioli, Laura Obici, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 4, 2012
Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II studyLaura Obici, Andrea Cortese, Alessandro Lozza, et al.Journal of Virology|February 23, 2007
Analysis of hepatitis C virus hypervariable region 1 sequence from cryoglobulinemic patients and associated controlsGabriella Bianchettin, Claudia Bonaccini, Romina Oliva, et al.British Journal of Haematology|October 20, 2017
Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trialAndrea Nozza, Fabrizia Terenghi, Francesca Gallia, et al.Blood|January 18, 2006
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemiaSteven P Treon, Morie A Gertz, Meletios Dimopoulos, et al.Leukemia|May 24, 2019
A revised international prognostic score system for Waldenström's macroglobulinemiaEfstathios Kastritis, Pierre Morel, Alain Duhamel, et al.American Journal of Hematology|March 6, 2012
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failureGiovanni Palladini, Andrea Foli, Paolo Milani, et al.Pageof 50